Nanoparticle Decoys Against COVID-19

  • Author:
  • Published: 11 October 2020
  • Copyright: Wiley-VCH GmbH
  • Source / Publisher: Proceedings of the National Academy of Sciences of the United States of America
thumbnail image: Nanoparticle Decoys Against COVID-19

The coronavirus SARS-CoV-2 causes the COVID-19 pandemic, and effective treatment options for COVID-19 are urgently needed. SARS-CoV-2 viruses have glycoprotein "spikes" on their surface. These spikes help the virus to enter host cells by binding to a receptor on the surface of the host cells' membrane—the angiotensin-converting enzyme 2 (ACE2). In severe cases of COVID-19, patients show elevated levels of inflammatory cytokines, signaling molecules important for the immune system. Such a "cytokine storm" can lead to life-threatening disease or even fatal outcomes.

Lu Lu, Youhua Xie, Shibo Jiang, Fudan University, Shanghai, China, Xiaoyuan Chen, National Institutes of Health (NIH), Bethesda, MD, USA, and colleagues have developed a nanodecoy made from engineered cell membranes that could neutralize both the virus and inflammatory cytokines. The team first genetically engineered human embryonic kidney 293T cells to express the ACE2 receptor. Then they collected cell-membrane nanovesicles from these engineered 293T/ACE2 cells and from THP-1 cells, a cell line that has abundant cytokine receptors. These two types of cell membrane were mixed to give fused nanovesicles via sonication and extrusion of the cell membranes through nanopores.

The resulting nanodecoys contain both abundant ACE2 receptors and cytokine receptors from the source cells. These nanodecoys can compete with healthy cells and bind both the SARS-CoV-2 virus and inflammatory cytokines, such as interleukin 6 (IL-6) and granulocyte-macrophage colony-stimulating factor (GM-CSF). The team used a mouse model for acute lung inflammation to show that the nanodecoys can prevent lung injury. However, the researchers point out that further studies and optimization will be necessary before such nanoparticles can be used to fight COVID-19.

Also of Interest

  • Collection: SARS-CoV-2 Virus
    What we know about the new coronavirus and COVID-19



Article Views: 3332

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH